The Latest Cardiac and Vascular News
IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has received approval from the Ethics Committee at Fundación Santa Fe de Bogotá […]
SAN FRANCISCO, July 24, 2018 /PRNewswire/ — CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next generation stent retriever used to capture and remove life-threatening blood clots […]
BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global healthcare company, highlighted the publication of OPTALYSE PE trial results in JACC: Cardiovascular Interventions. The published findings further confirm that bilateral pulmonary embolism (PE) treated in as little as 2 hours with EKOSⓇ Acoustic Pulse Thrombolysis™ therapy shows significant improvement in RV/LV ratio and […]
FAIRWAY, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), a medical device company developing innovative products for the treatment of neurovascular and peripheral vascular diseases, announced today that Dr. Kieran Murphy, Professor, Vice Chair and Director of Research in the Department of Medical Imaging at the University of Toronto, presented new nonclinical results from […]
FAIRWAY, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), a medical device company developing innovative products for the treatment of neurovascular and peripheral vascular diseases, announced today that Dr. Kieran Murphy, Professor, Vice Chair, and Director of Research in the Department of Medical Imaging at the University of Toronto, presented new nonclinical results from […]
Tel Aviv, Israel, July 23, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it has established its first two Centers of Excellence (COE) at leading […]
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) today announced the online publication of a report in the journal Circulation describing the mechanism of action of its phosphodiesterase (PDE) Type 1 inhibitor, ITI-214, and its potential use for the treatment of heart failure. In these preclinical studies, Johns […]
PLANO, Texas, July 23, 2018 /PRNewswire/ — MEDICALgorithmics, S.A. (WSE: MDG) and U.S. subsidiary Medi-Lynx Cardiac Monitoring L.L.C., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PocketECG Cardiac Rehabilitation System (CRS), a new mobile cardiac rehabilitation system designed to provide high-quality ECG monitoring and […]
TEL AVIV, Israel, July 23, 2018 /PRNewswire/ — Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, announces the first clinical cases of the Cascade Dynamic Non-Occlusive Remodeling Net earlier this month by Dr. Alejandro Tomasselo at Hospital Vall d’Hebron in Barcelona, Spain. The Cascade Net is the latest addition […]
MARLBOROUGH, Mass., July 20, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel® Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter […]
